A new strategy for synthesizing the kind of complex molecules that certain bacteria use to build their protective cell walls has been developed by Akihiro Ishiwata and Yukishige Ito from the RIKEN Advanced Science Institute in Wako. The strategy applies to Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), so it could lead to much-needed new medicines to combat the spread of multi-drug-resistant strains of the pathogen.
Disrupting the formation of the cell wall of M. tuberculosis is already a proven strategy for treating TB, with several of the current front-line drugs working in this way. However, the cell wall skeleton is a complex, highly branched structure, and its biosynthesis is not yet fully understood.
According to Ito, the compound he and Ishiwata made—a sugar-based structure known as the arabinan motif (Araf22) — should be a useful biological probe, helping to unravel cell wall biosynthesis. Perhaps more importantly, however, the success of their strategy suggests that larger, more complex cell wall components could be made in the same way.
Sugar-based compounds are notoriously difficult to make. Sugars are bristling with reactive alcohol groups, so molecules made from more than 20 sugar units pose a significant synthetic challenge. Nevertheless, Ishiwata and Ito succeeded in clipping together the branching chain of 22 sugar units needed to make Araf22.
Their strategy involved synthesizing small sub-structures of the mycobacterial cell wall skeleton and building from there. To make the compound, they conceptually broke down Araf22’s structure into several simpler fragments, chemically synthesized those fragments, and then clipped them together to make Araf22. This aspect of the strategy has been applied before, but Ishiwata and Ito built the fragments such that they clipped together at linear rather than branching points in their structure.
The researchers’ strategy makes the individual fragments more difficult to build, but it makes the coupling process much more efficient. Crucially, that means the strategy should work just as well as a way to make even larger and more complex components of the cell wall.
“One of the main points of this work is for us to show the way to construct the more complex compounds,” says Ishiwata. “We are now planning to synthesize more complex but structurally reliable glycans of cell wall skeletons for biological studies.” However, such compounds could even prove to be useful drugs in themselves, if they are able to disrupt the cellular machinery responsible for mycobacterial cell wall biosynthesis.
The corresponding author for this highlight is based at the Synthetic Cellular Chemistry Laboratory, RIKEN Advanced Science Institute
 Ishiwata A. & Ito Y. Synthesis of docosasaccharide arabinan motif of mycobacterial cell wall. Journal of the American Chemical Society 133, 2275–2291 (2011).
gro-pr | Research asia research news
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine